Effect of azelnidipine on angiotensin II-mediated growth-promoting signaling in vascular smooth muscle cells

Molecular Pharmacology

Volumn 67, Issue 5, 2005, Pages 1666-1673

  Li, Jian Mei ^a   Iwai, Masaru ^a   Cui, Tai Xing ^a   Min, Li Juan ^a   Tsuda, Masahiro ^a   Iwanami, Jun ^a   Suzuki, Jun ^a   Mogi, Masaki ^a   Horiuchi, Masatsugu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; AZELNIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; JANUS KINASE 2; JANUS KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; OLMESARTAN; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; STAT1 PROTEIN; STAT3 PROTEIN; THYMIDINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; AZETIDINECARBOXYLIC ACID; CELLS, CULTURED; DIHYDROPYRIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; MAP KINASE SIGNALING SYSTEM; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY;

EID: 17844364587     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.008144     Document Type: Article

References (33)

1. Berridge MJ (1993) Inositol triphosphate and calcium signaling. Nature (Lond) 361:315-325.
2. Brock TA, Alexander RW, Ekstein LS, Atkinson WJ, and Gimbrone MA (1985) Angiotensin increases cytosolic free calcium in cultured vascular smooth muscle cells. Hypertension 7 (Suppl I):I105-I109.
3. Cook SJ and McCormick F (1996) Kinetic and biochemical correlation between sustained p44EKK1 (44 kDa extracellular signal-regulated kinase 1) activation and lysophosphatidic acid-stimulated DNA synthesis in Rat-1 cells. Biochem J 320:237-245.
4. Cui TX, Nakagami H, Iwai M, Takeda Y, Shiuchi T, Tamura K, Daviet L, and Horiuchi M (2002) ATRAP, novel AT1 receptor associated protein, enhances internalization of ATI receptor and inhibits vascular smooth muscle cell growth. Biochem Biophys Res Commun 279:938-941.
5. de Gasparo M, Catt KJ, Inagami T, Wright JW, and Unger T (2000) International Union of Pharmacology, XXIII: the angiotensin II receptors. Pharmacol Rev 52:415-472.
6. Dol F, Schaeffer P, Lamarche I, Mrrie AM, Chatelain P, and Herbert JM (1995) Effect of SR 33805 on arterial smooth muscle cell proliferation and neointima formation following vascular injury. Eur J Pharmacol 280:135-142.
7. Dzau VJ (2001) Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 37:1047-1052.
8. Eguchi S and Inagami T (2000) Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. Regul Pept 91:13-20.
9. Force T and Bonventre JV (1998) Growth factors and mitogen-activated protein kinases. Hypertension 31:152-161.
10. Hirata A, Igarashi M, Yamaguchi H, Suwabe A, Daimon M, Kato T, and Tominaga M (2000) Nifedipine suppresses neointimal thickening by its inhibitory effect on vascular smooth muscle cell growth via a MEK-ERK pathway coupling with Pyk2. Br J Pharmacol 131:1521-1530.
11. Horiuchi M, Hayashida W, Akishita M, Tamura K, Daviet L, Lehtonen JYA, and Dzau VJ (1999) Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative crosstalk. Circ Res 84:876-882.
12. Izumi Y, Kim S, Namba M, Yasumoto H, Miyazaki H, Hoshiga M, Kaneda Y, Morishita R, Zhan Y, and Iwao H (2001) Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery. Circ Res 88:1120-1126.
13. Iversen BM and Arendshorst WJ (1998) Angiotensin II and vasopressin stimulate calcium entry in freshly isolated afferent arteriolar smooth muscle cells. Am J Physiol 503:237-251.
14. Jinno T, Iwai M, Li Z, Li JM, Liu HW, Cui TX, Rakugi H, Ogihara T, and Horiuchi M (2004) Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan. Hypertension 43:263-269.
15. Keyse SM (1995) An emerging family of dual specificity MAP kinase phosphatases. Biochim Biophys Acta 1265:152-160.
16. Ko Y, Totzke G, Graack GH, Heidgen FJ, Meyer zu Brickwedde MK, Dusing R, Vetter H and Sachinidis A (1993) Action of dihydropyridine calcium antagonists on early growth response gene expression and cell growth in vascular smooth muscle cells. J Hypertens 11:1171-1178.
17. Ko YD, Sachinidis A, Graack GH, Appenheimer M, Wieczorek AJ, Dusing R, and Vetter H (1992) Inhibition of angiotensin II and platelet-derived growth factor-induced vascular smooth muscle cell proliferation by calcium entry blockers. Clin Investig 70:113-117.
18. Kodama H, Fukuda K, Pan J, Makino S, Sano M, Takahashi T, Hori S, and Ogawa S (1997) Biphasic activation of the Jak/STAT pathway by angiotensin II in rat cardiomyocytes. Circ Res 82:244-250.
19. Kuriyama S, Tomonari H, Tokudome G, Horiguchi M, Hayashi H, Kobayashi H, Ishikawa M, and Hosoya T (2002) Antiproteinuric effects of combined antihypertensive therapies in patients with overt type 2 diabetic nephropathy. Hypertens Res 25:849-855.
20. Li G, Chen YF, Greene GL, Oparil S, and Thompson JA (1999) Estrogen inhibits vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro. Circulation 100:1639-1645.
21. 2+ channels in rat portal vein myocytes. J Biol Chem 272:23180-23185.
22. Nelson PR, Yamamura S, Mureebe L, Itoh H, and Kent KC (1998) Smooth muscle cell migration and proliferation are mediated by distinct phases of activation of the intracellular messenger mitogen-activated protein kinase. J Vasc Surg 27:117-125.
23. Pang L, Sawada T, Decker S, and Saltiel A (1995) Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 270:13585-13588.
24. Pelletier S, Duhamel F, Coulombe P, Popoff M, and Meloche S (2003) Rh family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors. Mol Cell Biol 23:1316-1333.
25. 2+ influx stimulate MEK and MAP kinase via activation of Ras. Neuron 12:1207-1221.
26. Rosen LB and Greenberg ME (1996) Stimulation of growth factor receptor signal transduction by activation of voltage-sensitive calcium channels. Proc Natl Acad Sci USA 93:1113-1118.
27. Sandberg EM, Ma X, YonderLinden D, Godeny MD, and Sayeski PP (2004) Jak2 tyrosine kinase mediates angiotensin II-dependent inactivation of ERK2 via induction of mitogen-activated protein kinase phosphatase 1. J Biol Chem 279:1956-1967.
28. Saward L and Zahradka P (1997) Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ Res 81:249-257.
29. Stepien O, Gogusev J, Zhu DL, Iouzalen L, Herembert T, Drueke TB, and Marche P (1998) Amlodipine inhibition of serum-, thrombin-, or fibroblast growth factor-induced vascular smooth muscle cell proliferation. J Cardiovasc Pharmacol 31:786-793.
30. Venema RC, Venema VJ, Eaton DC and Venema RC (1998) Angiotensin II-induced tyrosine phosphorylation of signal transducers and activators of transcription 1 is regulated by Janus-activated kinase 2 and Fyn kinases and mitogen-activated protein kinase phosphatase 1. J Biol Chem 273:30795-30800.
31. Viedt C, Soto U, Krieger-Brauer HI, Fei J, Elsing C, Kubler W, and Kreuzer J (2000) Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vase Biol 20:940-948.
32. Weber JD, Raben DM, Phillips PJ, and Baldassare JJ (1997) Sustained activation of extracellular signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J 326:61-68.
33. Wu YY and Bradshaw RA (1996) Induction of neurite outgrowth by interleukin-6 is accompanied by activation of Stat3 signaling pathway in a variant PC12 cell (E2) line. J Biol Chem 271:13023-13032.